Immune-mediated coagulopathy associated with topical bovine thrombin: Review of the pediatric literature

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 2, 2011, Pages 86-88

  Rodgers, George M ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

bovine thrombin; coagulopathy; factor V; postoperative bleeding

Indexed keywords

BLOOD CLOTTING FACTOR 5; DESMOPRESSIN; EVITHROM; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT THROMBIN; RECOTHROM; STEROID; THROMBIN; THROMBIN JMI; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ADOLESCENT; ANTIBODY PRODUCTION; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; CROSS REACTION; DRUG EFFICACY; DRUG REEXPOSURE; DRUG SAFETY; EXCHANGE BLOOD TRANSFUSION; HUMAN; IMMUNE MEDIATED COAGULOPATHY; INFANT; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANIMALS; AUTOANTIBODIES; BLOOD COAGULATION DISORDERS; CATTLE; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; INFANT; POSTOPERATIVE HEMORRHAGE; THROMBIN;

EID: 79952188396     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ff0e43     Document Type: Review

References (16)

1. Stricker RB, Lane PK, Leffert JD, et al. Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood. 1988;72:1375-1380. (Pubitemid 18265907)
2. Flaherty MJ, Henderson R, Wener MH. Iatrogenic immunization with bovine thrombin: A mechanism for prolonged thrombin times after surgery. Ann Intern Med. 1989;111: 631-634. (Pubitemid 19259180)
3. Dorion RP, Hamati HF, Landis B, et al. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med. 1998;122: 887-894. (Pubitemid 28485270)
4. Ness P, Creer M, Rodgers GM, et al. Building an immunemediated coagulopathy consensus: Early recognition andevaluation to enhance post-surgical safety. Patient Saf Surg. 2009;3:8.
5. Streiff MB, Ness PM. Acquired FV inhibitors: A needless iatrogenic complication of bovine thrombin exposure. Trans fusion. 2002;42:18-26.
6. Muntean W, Zenz W, Finding K, et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a twoyear- old child. Acta Paediatr. 1994;83:84-87. (Pubitemid 24072087)
7. Israels SJ, Israels ED. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin. Am J Pediatr Hematol Oncol. 1994;16:249-254. (Pubitemid 24223776)
8. Ortel TL, Charles LA, Keller FG, et al. Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. Am J Hematol. 1994;45:128-135. (Pubitemid 24092580)
9. Muntean W, Zenz W, Edlinger G, et al. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost. 1997;77:1223.
10. Tarantino MD, Ross MP, Daniels TM, et al. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. J Pediatr Hematol Oncol. 1997;19:226-231. (Pubitemid 27276289)
11. Savage WJ, Kickler TS, Takemoto CM. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure. Pediatr Blood Cancer. 2007;49:1025-1029. (Pubitemid 350022471)
12. Crow SS, Sullivan VV, Aysola AE, et al. Post-operative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. Ann Thorac Surg. 2007;83:1547-1549. (Pubitemid 46440760)
13. Bomgaars L, Carberry K, Fraser C, et al. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: A report of three cases. Congenit Heart Dis. 2010;5:303-308.
14. Chediak J, Ashenhurst JB, Garlick I, et al. Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions. Blood. 1980;56:835-841. (Pubitemid 11242976)
15. Cheng CM, Meyer-Massetti C, Kayser SR. A review of the three stand-alone topical thrombins for surgical hemostasis. Clin Ther. 2009;31:32-41.
16. Ballard JL, Weaver FA, Singla NK, et al. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin. J Am Coll Surg. 2010; 210:199-204.